{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:00:32Z","timestamp":1792036832865,"version":"4.4.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Large-scale sequencing studies of hematologic malignancies have revealed notable epistasis among high-frequency mutations. One of the most striking examples of epistasis occurs for mutations in RNA splicing factors. These lesions are among the most common alterations in myeloid neoplasms and generally occur in a mutually exclusive manner, a finding attributed to their synthetic lethal interactions and\/or convergent effects. Curiously, however, patients with multiple-concomitant splicing factor mutations have been observed, challenging our understanding of one of the most common examples of epistasis in hematologic malignancies. In this study, we performed bulk and single-cell analyses of patients with myeloid malignancy who were harboring \u22652 splicing factor mutations, to understand the frequency and basis for the coexistence of these mutations. Although mutations in splicing factors were strongly mutually exclusive across 4231 patients (q &amp;lt; .001), 0.85% harbored 2 concomitant bona fide splicing factor mutations, \u223c50% of which were present in the same individual cells. However, the distribution of mutations in patients with double mutations deviated from that in those with single mutations, with selection against the most common alleles, SF3B1K700E and SRSF2P95H\/L\/R, and selection for less common alleles, such as SF3B1 non-K700E mutations, rare amino acid substitutions at SRSF2P95, and combined U2AF1S34\/Q157 mutations. SF3B1 and SRSF2 alleles enriched in those with double-mutations had reduced effects on RNA splicing and\/or binding compared with the most common alleles. Moreover, dual U2AF1 mutations occurred in cis with preservation of the wild-type allele. These data highlight allele-specific differences as critical in regulating the molecular effects of splicing factor mutations as well as their cooccurrences\/exclusivities with one another.<\/jats:p>","DOI":"10.1182\/blood.2020006868","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T19:00:02Z","timestamp":1594234802000},"page":"1477-1486","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4407-6325","authenticated-orcid":false,"given":"Justin","family":"Taylor","sequence":"first","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"},{"name":"University of Miami Miller School of Medicine, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0348-1001","authenticated-orcid":false,"given":"Xiaoli","family":"Mi","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrystyna","family":"North","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences and"},{"name":"Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Genome Sciences, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-9658","authenticated-orcid":false,"given":"Moritz","family":"Binder","sequence":"additional","affiliation":[{"name":"Mayo Clinic Cancer Center, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-2370","authenticated-orcid":false,"given":"Alexander","family":"Penson","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra","family":"Lasho","sequence":"additional","affiliation":[{"name":"Mayo Clinic Cancer Center, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Knorr","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haddadin","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-614X","authenticated-orcid":false,"given":"Joseph","family":"Pangallo","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences and"},{"name":"Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Benbarche","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wiseman","sequence":"additional","affiliation":[{"name":"Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[{"name":"Mayo Clinic Cancer Center, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Halene","sequence":"additional","affiliation":[{"name":"Section of Hematology, Department of Internal Medicine and"},{"name":"Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Department of Hematologic Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Peoples Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-662X","authenticated-orcid":false,"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[{"name":"Mayo Clinic Cancer Center, Rochester, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8046-1063","authenticated-orcid":false,"given":"Robert K.","family":"Bradley","sequence":"additional","affiliation":[{"name":"Division of Public Health Sciences and"},{"name":"Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA;"},{"name":"Department of Genome Sciences, University of Washington, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6171","authenticated-orcid":false,"given":"Omar","family":"Abdel-Wahab","sequence":"additional","affiliation":[{"name":"Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7367","key":"2020092411285217600_B1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nature10496","article-title":"Frequent pathway mutations of splicing machinery in myelodysplasia","volume":"478","author":"Yoshida","year":"2011","journal-title":"Nature"},{"issue":"15","key":"2020092411285217600_B2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","article-title":"Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts","volume":"365","author":"Papaemmanuil","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2020092411285217600_B3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng.1031","article-title":"Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes","volume":"44","author":"Graubert","year":"2011","journal-title":"Nat Genet"},{"issue":"1","key":"2020092411285217600_B4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1101\/gr.181016.114","article-title":"U2AF1 mutations alter splice site recognition in hematological malignancies","volume":"25","author":"Ilagan","year":"2015","journal-title":"Genome Res"},{"issue":"5","key":"2020092411285217600_B5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","article-title":"Cancer-associated SF3B1 hotspot mutations induce cryptic 3\u2032 splice site selection through use of a different branch point","volume":"13","author":"Darman","year":"2015","journal-title":"Cell Rep"},{"issue":"5","key":"2020092411285217600_B6","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","article-title":"SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition","volume":"27","author":"Kim","year":"2015","journal-title":"Cancer Cell"},{"issue":"1","key":"2020092411285217600_B7","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1038\/ncomms7042","article-title":"Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome","volume":"6","author":"Madan","year":"2015","journal-title":"Nat Commun"},{"issue":"7728","key":"2020092411285217600_B8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"issue":"2","key":"2020092411285217600_B9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach","year":"2014","journal-title":"Leukemia"},{"issue":"22","key":"2020092411285217600_B10","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2020092411285217600_B11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ng.3742","article-title":"Dynamics of clonal evolution in myelodysplastic syndromes","volume":"49","author":"Makishima","year":"2017","journal-title":"Nat Genet"},{"issue":"2","key":"2020092411285217600_B12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2018.07.003","article-title":"Synthetic lethal and convergent biological effects of cancer-associated spliceosomal gene mutations","volume":"34","author":"Lee","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"2020092411285217600_B13","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat Commun"},{"issue":"500","key":"2020092411285217600_B14","doi-asserted-by":"crossref","first-page":"eaav5467","DOI":"10.1126\/scitranslmed.aav5467","article-title":"A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome","volume":"11","author":"Bondu","year":"2019","journal-title":"Sci Transl Med"},{"issue":"13","key":"2020092411285217600_B15","first-page":"1032","article-title":"Rare and private spliceosomal gene mutations drive partial, complete, and dual phenocopies of hotspot alterations","volume":"135","author":"Pangallo","year":"2020","journal-title":"Blood"},{"issue":"23","key":"2020092411285217600_B16","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"issue":"0","key":"2020092411285217600_B17","doi-asserted-by":"crossref","first-page":"bar026","DOI":"10.1093\/database\/bar026","article-title":"International Cancer Genome Consortium Data Portal--a one-stop shop for cancer genomics data","volume":"2011","author":"Zhang","year":"2011","journal-title":"Database (Oxford)"},{"issue":"1","key":"2020092411285217600_B18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"3","key":"2020092411285217600_B19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"2020092411285217600_B20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients [published correction appears in Nat Med. 2017;23:1004]","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"issue":"2","key":"2020092411285217600_B21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","article-title":"Accelerating discovery of functional mutant alleles in cancer","volume":"8","author":"Chang","year":"2018","journal-title":"Cancer Discov"},{"issue":"14","key":"2020092411285217600_B22","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2017-01-765107","article-title":"Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations","volume":"130","author":"Durham","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2020092411285217600_B23","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1101\/gr.232272.117","article-title":"High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics","volume":"28","author":"Pellegrino","year":"2018","journal-title":"Genome Res"},{"issue":"22","key":"2020092411285217600_B24","first-page":"2059","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia [published correction appears in N Engl J Med. 2013;369(1):98]","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"issue":"15","key":"2020092411285217600_B25","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Grinfeld","year":"2018","journal-title":"N Engl J Med"},{"key":"2020092411285217600_B26","doi-asserted-by":"crossref","unstructured":"Morita\n              K\n            , WangF, JahnK, et al\n          Clonal evolution of acute myeloid leukemia revealed by high throughput single-cell genomics.\n          bioRxiv. 2020. doi: 10.1101\/2020.02.07.925743.","DOI":"10.1101\/2020.02.07.925743"},{"issue":"7777","key":"2020092411285217600_B27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-019-1618-0","article-title":"Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis","volume":"574","author":"Yoshimi","year":"2019","journal-title":"Nature"},{"issue":"34","key":"2020092411285217600_B28","doi-asserted-by":"crossref","first-page":"E4726","DOI":"10.1073\/pnas.1514105112","article-title":"Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2020092411285217600_B29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/emboj.2011.367","article-title":"A syn-anti conformational difference allows SRSF2 to recognize guanines and cytosines equally well","volume":"31","author":"Daubner","year":"2012","journal-title":"EMBO J"},{"issue":"10","key":"2020092411285217600_B30","doi-asserted-by":"crossref","first-page":"e1006384","DOI":"10.1371\/journal.pgen.1006384","article-title":"Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival","volume":"12","author":"Fei","year":"2016","journal-title":"PLoS Genet"},{"issue":"26","key":"2020092411285217600_B31","doi-asserted-by":"crossref","first-page":"27039","DOI":"10.1074\/jbc.M402136200","article-title":"Diversity of vertebrate splicing factor U2AF35: identification of alternatively spliced U2AF1 mRNAS","volume":"279","author":"Pacheco","year":"2004","journal-title":"J Biol Chem"},{"issue":"6","key":"2020092411285217600_B32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"issue":"6","key":"2020092411285217600_B33","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/nm.4097","article-title":"Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins [published correction appears in Nat Med. 2016;22(6):692.]","volume":"22","author":"Lee","year":"2016","journal-title":"Nat Med"},{"issue":"10","key":"2020092411285217600_B34","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1158\/0008-5472.CAN-14-2930","article-title":"A chemical genetics approach for the functional assessment of novel cancer genes","volume":"75","author":"Zhou","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"2020092411285217600_B35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.celrep.2018.01.088","article-title":"Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types","volume":"23","author":"Seiler","year":"2018","journal-title":"Cell Rep"},{"issue":"26","key":"2020092411285217600_B36","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"2020092411285217600_B37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/bloodadvances.2019001127","article-title":"The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing","volume":"4","author":"Dalton","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"2020092411285217600_B38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2016.08.036","article-title":"Molecular architecture of SF3b and structural consequences of its cancer-related mutations","volume":"64","author":"Cretu","year":"2016","journal-title":"Mol Cell"},{"issue":"12","key":"2020092411285217600_B39","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1158\/2159-8290.CD-18-0877","article-title":"Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition","volume":"8","author":"Harding","year":"2018","journal-title":"Cancer Discov"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/13\/1477\/1758610\/bloodbld2020006868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/13\/1477\/1758610\/bloodbld2020006868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T15:32:30Z","timestamp":1600961550000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/13\/1477\/461285\/Singlecell-genomics-reveals-the-genetic-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,24]]},"references-count":39,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,9,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020006868","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,24]]}}}